Literature DB >> 34139879

Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals.

Michael G Berg1, Eitan Israeli2, Erin Quaco1, Gavin A Cloherty1, Philip M Hemken2.   

Abstract

Inactivation of SARS-CoV-2 virus is necessary to mitigate risk but may interfere with diagnostic assay performance. We examined the effect of heat inactivation on a prototype SARS-CoV-2 antigen immunoassay run on the ARCHITECT automated analyzer. Recombinant full-length SARS-CoV-2 nucleocapsid protein and virus lysate detection was reduced by 66 and 31%, respectively. Several nonionic detergents were assessed as inactivation alternatives based on infectivity in cultured Vero CCL81 cells. Incubation of SARS-CoV-2 in 0.1% Tergitol 15-S-9 for 10 min significantly reduced infectivity and increased the immunoassay signal for cultured lysate and patient specimens. Tergitol 15-S-9 can inactivate SARS-CoV-2 while preserving epitopes on the nucleocapsid protein for enhanced detection by immunoassay antibodies.

Entities:  

Keywords:  SARS-CoV-2; Tergitol 15-S-9; immunoassay; viral inactivation

Year:  2021        PMID: 34139879     DOI: 10.2144/btn-2021-0044

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  1 in total

1.  Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests.

Authors:  Mary A Rodgers; Ana Olivo; Barbara J Harris; Chris Lark; Xinxin Luo; Michael G Berg; Todd V Meyer; Aurash Mohaimani; Gregory S Orf; Yitz Goldstein; Amy S Fox; Julie Hirschhorn; William B Glen; Frederick Nolte; Alan Landay; Cheryl Jennings; James Moy; Venice Servellita; Charles Chiu; Rahul Batra; Luke B Snell; Gaia Nebbia; Sam Douthwaite; Amilcar Tanuri; Lavanya Singh; Tulio de Oliveira; Ambroise Ahouidi; Souleymane Mboup; Gavin A Cloherty
Journal:  J Clin Virol       Date:  2022-01-20       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.